Spain · AEMPS CIMA

AMLODIPINO/VALSARTAN CINFAMED 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
86131
Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Composition / generic term
valsartán + amlodipino
Source strength
5 mg/160 mg
Authorisation holder
Laboratorios Cinfa S.A.
Marketed in source snapshot
Yes

Source-listed ingredients

  • AMLODIPINO BESILATO — 6.9 mg
  • VALSARTAN — 160 mg

These values do not establish equivalence or a dose recommendation.

Packages

  • AMLODIPINO/VALSARTAN CINFAMED 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (OPA/Al/PVC-Alu)
  • AMLODIPINO/VALSARTAN CINFAMED 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos (PVC/PVDC-Alu)

Source and coverage

Open AEMPS CIMA →

Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Spain records →